JBF Capital’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

JBF Capital’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,639,127	Closed	-$1.07M	–	87
2023 Q1	$1.07M	Buy	2,639,127 +2,209,527	+514%	+$945K	0.24%	30
2022 Q4	$187K	Buy	+429,600	New	+$139K	0.05%	51

Other funds holding SIOX

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

JBF Capital's SIOX Position: Q2 2023 in Review

JBF Capital sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2023, closing a stake of 2,639,127 shares — an estimated $1.07M sold.

JBF Capital first reported a position in SIOX in Q4 2022 and held it in 2 quarters. The position peaked at $1.07M in Q1 2023. 1 fund tracked by Wall St. Rank holds SIOX as of Q2 2023.

JBF Capital reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
JBF Capital sold 2,639,127 Sio Gene Therapies Inc. Common Stock shares in Q2 2023, an estimated $1.07M.
JBF Capital first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2022 and held it in 2 quarters.
JBF Capital's Sio Gene Therapies Inc. Common Stock position peaked at $1.07M in Q1 2023.
1 fund tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2023.

Based on JBF Capital's 13F filing for Q2 2023, filed 11 Aug 2023.